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Leukemia inhibitory factor (LIF) is a polyfunctional molecule with significant and diverse biological activities. LIF is a glycoprotein secreted by 
a number of different cell types in vitro. It is induced in fibroblasts, lymphocytes, monocytes and astrocytes by various inducers such as serum, 
TNF, interleukin-IP and EGF. Due to extensive and variable glycosylation the molecular weight can range from 38 to 67 kDA. The biological 
functions of LIF are mediated through a receptor and a signal transducer, gp130, which is also used by factors like interleukind (IL-6), cilliary 
neurotropic factor (CNTF), and oncostatin M (OSM). Here, we report the crystallization of the non-glycosylated human-like LIF expressed in 
E. coli. The present crystals diffract to 2.0 A using synchrotron radiation. They belong to the monoclinic space group C2, and the cell dimensions 
area=61.5A,b=45.3A,c=77.7Aand,!I=112.3°. 
Cytokine; Isoelectric focusing; Crystal; Synchrotron radiation 
1. INTRODUCTION 
Leukemia inhibitory factor (LIF), also known as dif- 
ferentiation-inducing factor (Dfactor), human inter- 
leukin for DA cells (HILDA), cholinergic neuronal dif- 
ferentiation factor (CDF), hepatocyte-stimulating fac- 
tor III (HSF III), is a polyfunctional molecule [l]. LIF 
is a pluripotent glycoprotein with important regulatory 
physiological activities (for reviews, see [2-4]). These 
include its ability to induce maturation of murine and 
human leukemia cells, to direct phenotype expression in 
neuronal tissue, to induce changes in calcium metabo- 
lism, to promote acute phase protein synthesis in hepa- 
tocytes, and to increase platelet numbers. 
embryonic carcinoma cells, on a majority of lympho- 
cytes, myoblast, hepatocytes, osteoblasts, adipocytes 
and adrenal cortical cells. Some effects of LIF on these 
cells apear to be similar to the action of interleukin-6 
(IL-6) [7]: both trigger the immediate early response 
upon induction of differentiation of murine leukemic 
cells [8]. However, the differentiation inhibitory effect 
of LIF on embryonic stem cells is not shared by IL-6. 
LIF is produced by human epithelial cells. Cell lines 
such as Kreb’s ascites, Ehrlich ascites, STO, L929, buf- 
falo rat liver, H4 hepatoma, bladder cell carcinoma, 
osteoblastoma nd lung adenocarcinomas produce LIF 
in detectable amounts. It is induced by mitogens in 
spleen cells, and in alloreactive T lymphocytes upon 
antigen binding. During embryonic development, LIF 
is expressed in blastocysts, egg cylinders, and may play 
a crucial role in the implantation process [5,6]. LIF is 
a generalized stem cell factor as many of its actions 
appear to be mediated via stem cells or progenitor cells 
rather than by a direct effect on differentiated tissues 
[2-51. Receptors for LIF are present on cells of mon- 
ocytic and macrophagic series, on embryonic stem cells, 
Although there is no overall amino acid sequence 
homology between LIF, IL-6, and other cytokines 
which use gp130 for signal transduction (IL-l 1, on- 
costatin M, cilliary neurotropic factor [9]), they have a 
number of biological effects in common. Therefore, it 
is speculated that these cytokines may have similar ter- 
tiary structures [lo]. We have crystallized recombinant 
human LIF as a prerequisit of the structure analysis. 
The three-dimensional structure of LIF should help un- 
derstand the relationship of its structure and various 
functions. 
2. MATERIALS AND METHODS 
2.1. Crystallization of LIF 
*Corresponding author. 
A chemically synthesised gene for human LIF was expressed in E. 
coli under the heat-inducible pL promotor. LIF protein was purified 
from inclusion bodies using multiple chromatography steps [ll]. This 
preparation of endotoxin-free recombinant human LIF has been 
found to be active in a number of biological assays [12-141. Purified 
LIF was suspended in PBS and frozen in aliquots at -80°C. For the 
crystallization experiments, LIF was dialyzed extensively against 
water and lyophilized. Crystals of LIF were obtained by sitting drop 
vapour diffusion [15]. For the crystallization experiments, a concen- 
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tration of 10 mg/ml was used. Crystallization set-ups were performed 
at 16°C using 200 mM sodium acetate, 100 mM cacodylate buffer, pH 
6.0, with 30% w/v polyethylene glycol 8000 as precipitant. Plate-like 
crystals grew within about 20 days. 
2.2. Isoelectric focusing 
Gels (25 x 10 x 0.05 cm’) were prepared from 5% T/3% C acrylami- 
de and 0.2 M Immobiline solutions (Pharmacia). The mixtures of 
Immobiline species were calculated as in [16] to give a linear gradient 
from pH 6 to 11. Gels were equilibrated for 30 min in 2% glycerol, 
dried in air and re-swollen in 8 M urea containing 0.1% Tween 20 and 
0.5% ampholine (pH >lO; Pharmacia). Protein samples were applied 
in surface wells of the gradient gel mounted on a LKB multiphore 
apparatus. Focusing was performed for 17 h at 5,000 V after an initial 
period of 2 h at 500 V. Staining was carried out in Coumassie brilliant 
blue in the presence of Cu*+ [16]. 
3. RESULTS AND DISCUSSION 
The purity of recombinant LIF was assessed by poly- 
acrylamide gel electrophoresis. Fig. IA shows one single 
protein band migrating to 21 kDa which is in accord- 
ance with the molecular size of the LIF protein core 
derived from the cDNA sequence. Incomplete recombi- 
nant expression or proteolytic degradation can thus be 
excluded. Isoelectric focusing of LIF preparations, 
however, revealed a considerable charge heterogeneity: 
about 6 major and some minor components in the range 
between pH 8 and 10 were separated on immobilized 
pH gradients (Fig. 1B). Charge heterogeneity is not 
uncommon for preparations of ‘pure’ proteins, since 
post-translational modifications like deamidation or 
oxidation of thiol residues might have occurred. In spite 
of the presence of multiple LIF species crystallization 
of this preparation was possible. The sitting drop va- 
pour diffusion technique yielded crystals of up to 0.3 
mm diameter (Fig. 2) which grew in the form of plates 
and tended to stick together. Inspection of the crystals 
A 
21 kDa 
B 
under the microscope suggested a major component 
with one or more small satellites (or twins). As the 
crystals were small, it was not possible to separate the 
individual sections for diffraction experiments. For X- 
ray studies a crystal with a small satellite was mounted 
in a glass capillary. The dimensions of the crystal are 
0.3 x 0.3 x 0.1 mm3. This crystal was investigated using 
synchrotron radiation from the wiggler station D32 at 
the storage ring DCI, LURE, Orsay [17], using an 
EMBL Image Plate Scanner. The storage ring was oper- 
ating at 1.85 GeV and about 310 mA. The diffraction 
extended to about 2.0 8, resolution. From one sample, 
native data to 3.5 A were collected. The crystal-to-detec- 
tor distance was 350 mm. At a wavelength of 0.9 A, 34 
images were collected with a rotation range of de 3.0” 
per image. The pattern showed one major lattice accom- 
panied by some weak reflections from a smaller satellite 
(Fig. 2). The cell dimensions were preliminarily assigned 
using the program MOSFLM [ 181. The space group was 
assigned to be C2 with unit cell dimensions a = 61.5 A, 
b = 45.3 A, c = 77.7 A and /? = 112.3“. These yield a 
unit cell volume of 2.0 x lo6 A3 and a packing density 
parameter, V,, of 2.5 A3/Da assuming 1 molecule in the 
asymmetric unit [19]. The lattice is pseudo 1222. The 
data were integrated using the program DENZO [20]. 
The completeness of the native data is 99.4% and the 
RsF (I) is 3.5%. Attempts to solve the structure using 
molecular eplacement with the model of G colony stim- 
ulating factor from [21] are in progress and, in parallel, 
a heavy atom search has been initiated. Also, single LIF 
isoforms of discrete p1 values will be purified in novel 
multicompartment electrolyzer with isoelectric mem- 
branes [ 161. The limiting size and quality of LIF crystals 
obtained so far may be due to charge heterogeneity of 
the protein which is known to impair the crystallization 
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Fig. 1. Gel electrophoretic analysis and isoelectric focusing of LIF protein. (A) PAGE of 30 pg LIF (as well as protein markers) in the presence 
of dodecyl sulfate on a gel containing 9% acrylamide (routine protocol). (B) 40 pg LIF in an immobilized pH gradient (pH 6.&l 1.0); for details 
see section 2. 
237 
Volume 336, number 2 FEBSLETTERS December 1993 
Fig. 2. Crystals of LIE (A) A cluster of LIF crystals. (B) The plate-like crystal of LIF. 
process. As found for the crystallization of another pro- 
tein (EGF receptor [ 161; and manuscript in preparation) 
the structure analysis of LIF is also expected to benefit 
from the purification to single isoforms. 
As discussed above, LIF is a multifunctional mole- 
cule which shares biological activities and signal 
transduction pathway with other cytokine molecules. 
As the glycosylation is not actually required for biolog- 
ical activity in vitro or in vivo, this study will reveal an 
active conformation and will shed light on potential 
receptor binding sites as well as its mode of action. A 
structural comparison with other cytokines, such as 
granulocyte colony stimulating factor (GCSF) and IL- 
6, will be important to understand certain effects of LIF 
in signal transduction. Structure analysis of GCSF [21] 
and GMCSF [22] had been extremely useful in under- 
Fig. 3. Diffraction pattern of a LIF crystal recorded with an EMBL 
Image Plate Scanner, photographed from the screen of a VAXstation 
3100. The resolution extends to 3.5 A at the edge of the image. The 
exposure time was set to 7 min. The oscillation angle is 3’. The 
maximum resolution observed from this crystal was 2.0 A. The satel- 
lite diffraction is visible but was successfully allowed for during the 
data reduction. 
standing the mechanism of action of these two cyto- 
kines. Information obtained from the three dimensional 
structure of LIF will also make it possible to design 
analogs and antagonists which will help to elucidate its 
pluripotent activities. 
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